---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-029939"
form_type: "8-K"
ticker: "BTCY"
cik: "0001630113"
company_name: "BIOTRICITY INC."
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T13:50:55.709831+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Biotricity receives Nasdaq bid price deficiency notice; 180-day cure period to Jan 22, 2025

## Summary
- Closing bid price below $1.00 for 30 consecutive business days triggers Nasdaq Listing Rule 5550(a)(2) deficiency.
- Company has until January 22, 2025 to regain compliance with minimum $1.00 closing bid for 10 consecutive days.
- If non-compliant by Jan 22, may receive additional 180-day period to cure, subject to other listing standards.
- Biotricity intends to monitor bid price and consider available options, including a reverse stock split.
- No immediate impact on Nasdaq listing or trading of BTCY common stock.

## SEC filing metadata
- accession: 0001493152-24-029939
- form_type: 8-K
- ticker: BTCY
- cik: 0001630113
- company_name: BIOTRICITY INC.
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630113/000149315224029939/0001493152-24-029939-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630113/000149315224029939/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-029939
- JSON: https://secwatch.observer/filing/0001493152-24-029939.json
- Plain text: https://secwatch.observer/filing/0001493152-24-029939.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.